<DOC>
	<DOC>NCT01361412</DOC>
	<brief_summary>The aim of the study is to identify changes in potential biomarkers after peptide immunotherapy for that may subsequently be developed as biomarkers that correlate with clinical efficacy.</brief_summary>
	<brief_title>Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
	<criteria>Enrolled in study TR002 but have not yet commenced dosing None; no criteria additional to TR002 exclusion criteria are applicable to this study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>ragweed allergy</keyword>
	<keyword>immunotherapy</keyword>
</DOC>